Fig. 5. Proliferation status of WT and Foxl2lacZ
homozygous mutant ovaries. (A-D) High magnifications of Hematoxylin and Eosin
stainings showing WT and Foxl2lacZ homozygous
mutant follicles 2 weeks and 8 weeks after birth. (A) Secondary follicle in WT
ovaries 2 weeks after birth (black arrow, cuboidal granulosa cells; o,
oocyte). (B) Primordial follicles in mutant ovaries 2 weeks after birth (white
arrow, squamous granulosa cells; o, oocyte). (C) Preantral follicle in WT
ovaries 8 weeks after birth (black arrow, cuboidal granulosa cells; o,
oocyte). (D) Atretic follicles in mutant ovaries 8 weeks after birth (black
arrow, squamous-like granulosa cells; o, oocyte). (E-H) Detection of apoptosis
by TUNEL assay in WT and Foxl2-deficient follicles. (E,F) There is almost no
apoptosis detectable in WT or in Foxl2lacZ
homozygous mutant ovaries 2 weeks after birth. (G) An antral follicle in an
8-week-old WT ovary showing apoptotic nuclei in the granulosa cells. (H)
Atretic follicles in 8-week-old mutant ovaries stain positive in the
squamous-like granulosa cells. (I-L) Staining of control and
Foxl2lacZ homozygous mutant ovaries with an
anti-PCNA antibody. (I) Two weeks after birth granulosa cells in primary and
secondary follicles stain positive for PCNA, whereas no staining is detectable
in Foxl2lacZ homozygous mutant ovaries (J). (K)
Positive PCNA staining in granulosa cells of an antral follicle in the WT
ovaries. (L) In contrast, no staining was observed in the mutant ovary.